Bivalent ligand that activates mu opioid receptor and antagonizes mGluR5 receptor reduces neuropathic pain in mice-Reference-Cited by-同舟云学术

Bivalent ligand that activates mu opioid receptor and antagonizes mGluR5 receptor reduces neuropathic pain in mice

Published:2017-09-01 Issue:12 Volume:158 Page:2431-2441
ISSN:0304-3959
Container-title:Pain
language:en
Short-container-title:PAIN

Author:

Peterson Cristina D.,Kitto Kelley F.,Akgün Eyup,Lunzer Mary M.,Riedl Maureen S.,Vulchanova Lucy,Wilcox George L.,Portoghese Philip S.,Fairbanks Carolyn A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine,Clinical Neurology,Neurology

Reference66 articles.

1. MDAN-21: a bivalent opioid ligand containing mu-agonist and delta-antagonist pharmacophores and its effects in rhesus monkeys;Aceto;Int J Med Chem,2012

2. Ligands that interact with putative MOR-mGluR5 heteromer in mice with inflammatory pain produce potent antinociception;Akgun;Proc Natl Acad Sci U S A,2013

3. Functionalization at position 3 of the phenyl ring of the potent mGluR5 noncompetitive antagonists MPEP;Alagille;Bioorg Med Chem Lett,2005

4. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain;Arner;PAIN,1988

5. Pharmacotherapy of neuropathic pain: which drugs, which treatment algorithms?;Attal;PAIN,2015

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The opioid receptor: emergence through millennia of pharmaceutical sciences;Frontiers in Pain Research;2023-11-01

2. Study of G protein-coupled receptors dimerization: From bivalent ligands to drug-like small molecules;Bioorganic Chemistry;2023-11

3. MMG22 Potently Blocks Hyperalgesia in Cisplatin-treated Mice;Neuroscience;2023-04

4. Review of Neuraxial Agents Producing Analgesia;Neuraxial Therapeutics;2023

5. Approaching GPCR Dimers and Higher‐Order Oligomers Using Biophysical, Biochemical, and Proteomic Methods;GPCRs as Therapeutic Targets;2022-09-16